Adult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohort

Journal of the International AIDS Society

Volumn 15, Issue 2, 2012, Pages

  Divaris, Kimon ^a,b   Newman, Jamie ^c   Hemingway Foday, Jennifer ^c   Akam, Wilfred ^d   Balimba, Ashu ^e   Dusengamungu, Cyrille ^f   Kalenga, Lucien ^g   Mbaya, Marcel ^g   Molu, Brigitte Mfangam ^h   Mugisha, Veronicah ⁱ   Mukumbi, Henri ^g   Mushingantahe, Jules ^j   Nash, Denis ^k   Niyongabo, Theodore ^l   Atibu, Joseph ^m   Azinyue, Innocent ⁿ   Kiumbu, Modeste ^m   Woelk, Godfrey ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c RTI INTERNATIONAL   (United States)

^d Limbe Provincial Hopital   (Cameroon)

^e Hôpital Militaire de Yaoundé   (Cameroon)

^f Kibuye District Hospital   (Rwanda)

^g Hopital General de Yaounde ^*  (Democratic Republic Congo)

^h YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

ⁱ Muhima District Hospital ^*  (United States)

^j Department of Obstetrics and Gynecology Muhima Hospital   (Rwanda)

^k Och Spine at New York Presbyterian Hospitals   (United States)

^l Centre Hospitalo Universitaire de Kamenge   (Burundi)

^m Ecole de Sante Publique   (Democratic Republic Congo)

ⁿ Vindata Solutions   (Cameroon)

more..

Author keywords

Central Africa; Clinical cohort; HIV care and treatment; Resource limited settings

Indexed keywords

LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BURUNDI; CAMEROON; CENTRAL AFRICA; CONGO; FEASIBILITY STUDY; FEMALE; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RWANDA; SECONDARY HEALTH CARE; TERTIARY HEALTH CARE; URBAN POPULATION; VIRUS TRANSMISSION; AFRICA; COHORT ANALYSIS; HEALTH CARE DELIVERY;

ADULT; AFRICA, CENTRAL; AFRICA, EASTERN; ANTI-HIV AGENTS; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE;

EID: 84877301748     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.15.2.17422     Document Type: Article

References (61)

1. UNAIDS [Internet]. Joint action for results: UNAIDS outcome framework 2009-2011. [cited 2012 Sep 28]. Available from: http://data.unaids.org/pub/ BaseDocument/2010/jc1713-joint-action-en.pdf
2. Hammer SM, Eron JJ, Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555-70.
3. Mahy M, Warner-Smith M, Stanecki KA, Ghys PD. Measuring the impact of the global response to the AIDS epidemic: challenges and future directions. J Acquir Immune Defic Syndr. 2009;52:S152-9.
4. UNAIDS [Internet]. AIDS epidemic. [updated 2009; cited 2012 Sep 28]. Available from: http://data.unaids.org/pub/Report/2009/2009-epidemic- update-en.pdf
5. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-24.
6. Zachariah R, Ford N, Philips M, Lynch S, Massaquoi M, Janssens V, et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub- Saharan Africa. Trans R Soc Trop Med Hyg. 2009;103:549-58.
7. Asamoah-Odei E, Garcia Calleja JM, Boerma JT. HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences. Lancet. 2004;364:35-40.
8. Egger M, Boulle A. Population effect of scaling up ART in resource-poor settings. Lancet. 2008;371:1558-9.
9. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505-10.
10. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
11. Zachariah R, Harries AD, Philips M, Arnould L, Sabapathy K, O'Brien DP, et al. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg. 2010;104:387-91.
12. Boyer S, Eboko F, Camara M, Abe C, Nguini ME, Koulla-Shiro S, et al. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010;24:S5-15.
13. Walsh A, Ndubani P, Simbaya J, Dicker P, Brugha R. Task sharing in Zambia: HIV service scale-up compounds the human resource crisis. BMC Health Serv Res. 2010;10:272.
14. van Damme W, Kober K, Laga M. The real challenges for scaling up ART in sub Saharan Africa. AIDS. 2006;20:653-6.
15. Collins C, Coates TJ, Szekeres G. Accountability in the global response to HIV: measuring progress, driving change. AIDS. 2008;22:S105-11.
16. Piot P, Bartos M, Ghys PD,Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature. 2001;410:968-73.
17. United Nations [Internet]. Millennium development goals. [cited 2012 Sep 28]. Available from: http://www.un.org/millenniumgoals/aids.shtml
18. Swiss HIV Cohort Study, Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol. 2010;39:1179-89.
19. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987;126:310-8.
20. Bendavid E, Bhattacharya J. The President's emergency plan for AIDS relief in Africa: an evaluation of outcomes. Ann Intern Med. 2009;150:688-95.
21. Bennett S, Boerma JT, Brugha R. Scaling up HIV/AIDS evaluation. Lancet. 2006;367:79-82.
22. Boerma JT, Stanecki KA, Newell ML, Luo C, Beusenberg M, Garnett GP, et al. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ. 2006;84:145-50.
23. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007;36:294-301.
24. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, et al. Cohort profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007;36:969-76.
25. Egger M, Ekouevi DK, Williams C, Lyamuya RE, Mukumbi H, Braitstein P, et al. Cohort profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol. 2012;41:1256-64.
26. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance[Internet]. Epidemiological fact sheet on HIV and AIDS. Core data on epidemiology and response. Burundi [updated 2008; cited 2012 Sep 28]. Available from: http://apps.who.int/globalatlas/predefinedReports/EFS2008/ full/EFS2008-BI.pdf
27. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance [Internet]. Epidemiological fact sheet on HIV and AIDS. Core data on epidemiology and response. Cameroon [updated 2008; cited 2012 Sep 28]. Available from: http://apps.who.int/globalatlas/predefinedReports/EFS2008/ full/EFS2008-CM.pdf
28. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance [Internet]. Epidemiological fact sheet on HIV and AIDS. Core data on epidemiology and response. Democratic Republic of the Congo; 2008 [updated 2008; cited 2012 Sep 28]. Available from: http://apps.who.int/globalatlas/ predefinedReports/EFS2008/full/EFS2008-CD.pdf
29. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance [Internet]. Epidemiological fact sheet on HIV and AIDS. Core data on epidemiology and response. Rwanda; 2008 [updated 2008; cited 2012 Sep 28]. Available from: http://apps.who.int/globalatlas/predefinedReports/EFS 2008/full/EFS2008-RW.pdf
30. Heidari S, Harries AD, Zachariah R. Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa. J Int AIDS Soc. 2011;14:S1.
31. Zachariah R, Van Damme W, Arendt V, Schmit JC, Harries AD. The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research. J Int AIDS Soc. 2011;14:S7.
32. Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. J Infect Dis. 2007;196(Suppl 3):S516-22.
33. Dong K, Thabethe Z, Hurtado R, Sibaya T, Dlwati H, Walker B, et al. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. J Infect Dis. 2007;196(Suppl 3):S491-6.
34. Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R. Obstaclesand proposed solutions to effective antiretroviral therapy in resource-limited settings. J Int Assoc Physicians AIDS Care (Chic). 2009;8:253-68.
35. Cailhol J, Mathole T, Parsons A, Sanders D, Kandondo D, Ndayiragije I, et al. Burundi: building a health system together with global health initiatives, in the aftermath of war. In: The maximizing positive synergies academic consortium: interactions between global health initiatives and health systems: evidence from countries [Internet]. 2009. pp. 8-19 [cited 2012 Sep 28]. Available from: http://www.who.int/healthsystems/publications/MPS-academic-case- studies-Book-01.pdf
36. Boyer S, Eboko F, Camara M, Abe C, Owona Nguini ME, Koulla-Shiro S, et al. Cameroon: evaluation of the national programme for access to antiretroviral therapy. In: The maximizing positive synergies academic consortium: interactions between global health initiatives and health systems: evidence from countries [Internet]. 2009. pp. 20-30 [cited 2012 Sep 28]. Available from: http://www.who.int/healthsystems/publications/ MPS-academic-case-studies-Book- 01.pdf
37. Loubiere S, Boyer S, Protopopescu C, Bonono CR, Abega SC, Spire B, et al. Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy. 2009;92:165-73.
38. Boyer S, Eboko F, Camara M, Abe C, Nguini ME, Koulla-Shiro S, et al. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010;24 (Suppl 1):S5-15.
39. Mukherjee JS, Jerome JG, Sullivan E, May MA, Mayfield A, Lambert W, et al. Rwanda: the impact of global health initiatives on the health system: a mixed methods analysis. In: The maximizing positive synergies academic consortium: interactions between global health initiatives and health systems: evidence from countries [Internet]. 2009. pp. 144-59 [cited 2012 Sep 28]. Available from:http://www.who.int/healthsystems/publications/MPS- academic-case-studies-Book-01.pdf
40. Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, et al. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaounde , Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health. 2008;13:1470-8.
41. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63.
42. Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009;23:203-10.
43. Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20:649-57
44. Fredlund VG, Nash J. How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007;196(Suppl 3):S469-73.
45. Martinot A, Van Rie A, Mulangu S, Mbulula M, Jarrett N, Behets F, et al. Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo. Trop Doct. 2008;38:137-41.
46. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006;42:377-782.
47. Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, et al. Financial barriers to HIV treatment in Yaounde , Cameroon: first results of a national cross-sectional survey. Bull World Health Organ. 2009;87:279-87.
48. Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6:83-97.
49. Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6:e1000066.
50. WHO/UNAIDS/UNICEF [Internet]. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2010 [cited 2012 Sep 28]. Available from: http://www.who.int/entity/hiv/pub/ towards-universal-access-report-2008.pdf
51. El-Sadr WM, Hoos D. The President's Emergency Plan for AIDS Relief-is the emergency over? N Engl J Med.2008;359:553-5.
52. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374:921-33.
53. McNaghten AD, Hanson DL, Dworkin MS, Jones JL. Adult/Adolescent Spectrum of HIV Disease Group. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2003;32:499-505.
54. Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199:991-8.
55. Hawkins C, Chalamilla G, Okuma J, Spiegelman D, Hertzmark E, Aris E, et al. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS. 2011;25:1189-97.
56. Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother. 2007;60:724-32.
57. Marcellin F, Abe C, Loubiere S, Boyer S, Blanche J, Koulla-Shiro S, et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS. 2009;23:1015-9.
58. Mavhu W, Dauya E, Bandason T, Munyati S, Cowan FM, Hart G, et al. Chronic cough and its association with TB-HIV co-infection: factors affecting help-seeking behaviour in Harare, Zimbabwe. Trop Med Int Health. 2010;15:574-9.
59. Boyer S, Clerc I, Bonono CR, Marcellin F, Bile PC, Ventelou B. Nonadherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: individual and healthcare supply-related factors. Soc Sci Med. 2011;72:1383-92.
60. Newman J, Torres P, Azinyue I, Hemingway-Foday J, Atibu J, Akam W, et al. Improvement of service capabilities following the establishment of an electronic database to evaluate AIDS in Central Africa. J Health Inform Dev Ctries. 2011;5:273-85.
61. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes inlower-income countries. Bull World Health Organ. 2008;86:559-67. Diseases